Abstract Background Bireociclib (XZP‐3287) is a novel selective cyclin‐dependent kinase 4 and 6 (CDK4/6) inhibitor, with a favorable safety profile demonstrated in preclinical and phase I studies. BRIGHT‐1 aimed to further explore the efficacy and safety of bireociclib monotherapy in patients with locally advanced, recurrent or metastatic, hormone ...
Jiayu Wang+18 more
wiley +1 more source
Extracting scalar measures from functional data with applications to placebo response. [PDF]
Tarpey T+3 more
europepmc +1 more source
Efficacy and safety of abatacept or infliximab vs placebo in ATTEST: a phase III, multi-centre, randomised, double-blind, placebo-controlled study in patients with rheumatoid arthritis and an inadequate response to methotrexate [PDF]
Michael Schiff+12 more
openalex +1 more source
Medical practice and placebo response: an inseparable bond? [PDF]
Jilch S, Sel R, Shariat SF.
europepmc +1 more source
Revelation of a personal placebo response: Its effects on mood, attitudes and future placebo responding [PDF]
Karen S. Chung+3 more
openalex +1 more source
Neutrophils in cancer: At the crucial crossroads of anti‐tumor and pro‐tumor
Abstract Neutrophils are important components of the immune system and play a key role in defending against pathogenic infections and responding to inflammatory cues, including cancer. Their dysregulation indicates potential disease risk factors. However, their functional importance in disease progression has often been underestimated due to their ...
Wenpeng Cai+6 more
wiley +1 more source
Baseline severity and the prediction of placebo response in clinical trials for alcohol dependence: A meta-regression analysis to develop an enrichment strategy. [PDF]
Scherrer B+26 more
europepmc +1 more source
Mechanism(s) of the Placebo Response and the Future of Neurofeedback Research
Theodore J. La Vaque
openalex +2 more sources
1557: Relationship between Screening IPSS and the Placebo Run-In Response in the Pooled Reduce and Combat Population [PDF]
Claus G. Roehrborn+4 more
openalex +1 more source
Citrus Flavonoids as Antimicrobials
Citrus flavonoids are powerful and versatile antimicrobials whose mechanism of action often involves disruption of the bacterial membrane, thereby minimizing antimicrobial resistance. This study provides a unified perspective. ABSTRACT Citrus flavonoids are highly bioactive compounds exerting numerous health benefits including anticancer, antioxidant ...
Rosaria Ciriminna+6 more
wiley +1 more source